These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
436 related articles for article (PubMed ID: 28208176)
1. Postapproval Observational Studies of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation. Potpara TS; Lip GY JAMA; 2017 Mar; 317(11):1115-1116. PubMed ID: 28208176 [No Abstract] [Full Text] [Related]
2. Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study. Larsen TB; Skjøth F; Nielsen PB; Kjældgaard JN; Lip GY BMJ; 2016 Jun; 353():i3189. PubMed ID: 27312796 [TBL] [Abstract][Full Text] [Related]
3. A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants. Halvorsen S; Ghanima W; Fride Tvete I; Hoxmark C; Falck P; Solli O; Jonasson C Eur Heart J Cardiovasc Pharmacother; 2017 Jan; 3(1):28-36. PubMed ID: 27680880 [TBL] [Abstract][Full Text] [Related]
4. Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups. Lip GY; Mitchell SA; Liu X; Liu LZ; Phatak H; Kachroo S; Batson S Int J Cardiol; 2016 Feb; 204():88-94. PubMed ID: 26655548 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study. Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GY; Larsen TB BMJ; 2017 Feb; 356():j510. PubMed ID: 28188243 [No Abstract] [Full Text] [Related]
6. Impact of new oral anticoagulants on gastrointestinal bleeding in atrial fibrillation: A meta-analysis of interventional trials. Loffredo L; Perri L; Violi F Dig Liver Dis; 2015 May; 47(5):429-31. PubMed ID: 25732432 [TBL] [Abstract][Full Text] [Related]
7. Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation. Di Lullo L; Ronco C; Cozzolino M; Russo D; Russo L; Di Iorio B; De Pascalis A; Barbera V; Galliani M; Vitaliano E; Campana C; Santoboni F; Bellasi A Thromb Res; 2017 Jul; 155():38-47. PubMed ID: 28482261 [TBL] [Abstract][Full Text] [Related]
8. A comparison between vitamin K antagonists and new oral anticoagulants. Jolobe OMP Br J Clin Pharmacol; 2017 Nov; 83(11):2589-2590. PubMed ID: 28703392 [No Abstract] [Full Text] [Related]
9. Comparing the Cost Effectiveness of Non-vitamin K Antagonist Oral Anticoagulants with Well-Managed Warfarin for Stroke Prevention in Atrial Fibrillation Patients at High Risk of Bleeding. Hospodar AR; Smith KJ; Zhang Y; Hernandez I Am J Cardiovasc Drugs; 2018 Aug; 18(4):317-325. PubMed ID: 29740750 [TBL] [Abstract][Full Text] [Related]
10. Which oral anticoagulant for atrial fibrillation. Med Lett Drugs Ther; 2016 Apr; 58(1492):45-6. PubMed ID: 27049507 [No Abstract] [Full Text] [Related]
11. Analysis of Recurrent Stroke Volume and Prognosis between Warfarin and Four Non-Vitamin K Antagonist Oral Anticoagulants' Administration for Secondary Prevention of Stroke. Kanai Y; Oguro H; Tahara N; Matsuda H; Takayoshi H; Mitaki S; Onoda K; Yamaguchi S J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):338-345. PubMed ID: 29033229 [TBL] [Abstract][Full Text] [Related]
12. Acute management of stroke patients taking non-vitamin K antagonist oral anticoagulants Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry: Design and rationale. Xian Y; Hernandez AF; Harding T; Fonarow GC; Bhatt DL; Suter RE; Khan Y; Schwamm LH; Peterson ED Am Heart J; 2016 Dec; 182():28-35. PubMed ID: 27914497 [TBL] [Abstract][Full Text] [Related]
13. [COMPARATIVE EFFECTIVENESS AND SAFETY OF NEW ORAL ANTICOAGULANTS AND WARFARIN IN PATIENTS WITH AGE-SPECIFIC NON-VALVULAR ATRIAL FIBRILLATION]. Shevelev VI; Kanorsky SG Klin Med (Mosk); 2015; 93(7):30-6. PubMed ID: 26596056 [TBL] [Abstract][Full Text] [Related]
14. Comparative Clinical Outcomes of Edoxaban in Adults With Nonvalvular Atrial Fibrillation. Aronow WS; Shamliyan TA Am J Ther; 2020; 27(3):e270-e285. PubMed ID: 30277905 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of bleeding complications due to oral anticoagulant drugs]. Riess H Laryngorhinootologie; 2015 Oct; 94(10):697-709. PubMed ID: 26468622 [No Abstract] [Full Text] [Related]
16. Safety and Effectiveness of Dabigatran and Other Direct Oral Anticoagulants Compared With Warfarin in Patients With Atrial Fibrillation. Huybrechts KF; Gopalakrishnan C; Bartels DB; Zint K; Gurusamy VK; Landon J; Schneeweiss S Clin Pharmacol Ther; 2020 Jun; 107(6):1405-1419. PubMed ID: 31869437 [TBL] [Abstract][Full Text] [Related]
17. Comparing the Efficacy and Safety of Direct Oral Anticoagulants With Warfarin in the Morbidly Obese Population With Atrial Fibrillation. Kido K; Ngorsuraches S Ann Pharmacother; 2019 Feb; 53(2):165-170. PubMed ID: 30130979 [TBL] [Abstract][Full Text] [Related]
18. Direct Oral Anticoagulants Versus Vitamin K Antagonists in Real-life Patients With Atrial Fibrillation. A Systematic Review and Meta-analysis. Escobar C; Martí-Almor J; Pérez Cabeza A; Martínez-Zapata MJ Rev Esp Cardiol (Engl Ed); 2019 Apr; 72(4):305-316. PubMed ID: 29606361 [TBL] [Abstract][Full Text] [Related]